P-847. Antimicrobial Stewardship in a Hospital-at-Home Program: Impact on Antibiotic Duration and Clinical Outcomes in Patients with Community-Acquired Pneumonia
Charles Jensen, Sky R Blue, Cathy Hitt Piechowski, Cathy Oliphant, Lizveth Lopez

TL;DR
This study shows that intensive antimicrobial stewardship in a Hospital-at-Home program improves antibiotic use without harming patient outcomes for pneumonia.
Contribution
The study demonstrates the effectiveness of embedded, intensive antimicrobial stewardship in a Hospital-at-Home model for pneumonia treatment.
Findings
HaH patients had significantly higher guideline adherence (84% vs 58%) and shorter β-lactam therapy duration (5.8 vs 6.8 days).
HaH showed trends toward reduced IV duration, fluoroquinolone use, and azithromycin exposure, with no difference in clinical outcomes.
Intensive stewardship in HaH could reduce 233 IV and 466 total antibiotic days if applied broadly.
Abstract
Hospital-at-Home (HaH) programs face unique antimicrobial management challenges. We embedded our Antimicrobial Stewardship Program at the launch of a new HaH initiative to review all antimicrobials—an intensity not standard in traditional inpatient (TI) settings at our health system. We compared CAP outcomes between these care models.Figure 1.Patient Selection FlowchartTable 1.Baseline CharacteristicsAbbreviations: HaH, Hospital at Home; TI, Traditional Inpatient; PSI; Pneumonia Severity Index. Patient Selection Flowchart Baseline Characteristics Abbreviations: HaH, Hospital at Home; TI, Traditional Inpatient; PSI; Pneumonia Severity Index. We retrospectively compared adult CAP patients (PSI scores 71-130) treated in TI versus HaH from November 2024-April 2025. Patients with alternate diagnoses or in-hospital death were excluded. Patients were randomly selected at a 2:1 ratio. TI…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNosocomial Infections in ICU · Antibiotic Use and Resistance · Antibiotic Resistance in Bacteria
